AILOS Robotics is redefining actuation for next-generation robotics with its patented gearbox technology
Helping clinicians make faster, smarter decisions with AI-powered alerts for patient deterioration.
Pleevi provides AI-driven smart charging solutions that optimize energy usage for electric vehicles.
Tanai Therapeutics is developing a first-in-class oral therapeutic for obesity.
eyeo develops breakthrough color-splitting photonics for ultra-compact, high-performance imaging
.png)
Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products
Flindr aims to restore a patient’s impaired immune response to cancer
Qbic fund is a seed and early-stage venture capital fund, supporting spin-offs or start-ups that valorize research from Qbic's knowledge partners.
A knowledge partner spin-off, i.e. a company that was founded based on technological innovations originating at Qbic's partner universities, research institutes or hospitals.
A start-up linked to a knowledge partner, i.e. a company with a strong R&D collaboration with one of Qbic's knowledge partners. This collaboration can be structured through joint development contracts, clinical studies, IP license agreements, etc.
